A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients
2017 · BMC Cancer · 72 citations
https://doi.org/10.1186/s12885-017-3131-x
B
Berta Laquente
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
76
Papers
874
Citations
16
h-index
20
i10-index
Berta Laquente is an academic researcher from Institut Català d'Ornitologia. The author has contributed to research in topics: Pancreatic and Hepatic Oncology Research & Gallbladder and Bile Duct Disorders & Cholangiocarcinoma and Gallbladder Cancer Studies. The author has an h-index of 16, co-authored 65 publications.
ORCID: 0000-0002-2477-1673Papers by this author
worksA randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features
2015 · BMC Cancer · 49 citations
https://doi.org/10.1186/s12885-015-1053-z
Quality of life of patients with metastatic pancreatic adenocarcinoma initiating first-line chemotherapy in routine practice
2020 · BMC Palliative Care · 16 citations
https://doi.org/10.1186/s12904-020-00610-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat